Contemporary use of antiplatelet therapies in percutaneous coronary interventions

被引：2
作者：
Saw, J [1 ]
Moliterno, DJ [1 ]
机构：
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
来源：
CORONARY ARTERY DISEASE | 2003年 / 14卷 / 05期
关键词：
antiplatelet agents; stents; angioplasty; aspirin; thienopyridine; glycoprotein IIb/IIIa inhibitors; clopidogrel;
D O I：
10.1097/00019501-200308000-00004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：373 / 380
页数：8
相关论文
共 50 条
  • [21] Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention
    Otsuka, Tatsuhiko
    Ueki, Yasushi
    Kavaliauskaite, Raminta
    Zanchin, Thomas
    Bar, Sarah
    Stortecky, Stefan
    Pilgrim, Thomas
    Valgimigli, Marco
    Meier, Bernhard
    Heg, Dik
    Windecker, Stephan
    Raber, Lorenz
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (02) : E213 - E221
  • [22] Antiplatelet and Anticoagulant Therapies in Acute Coronary Syndromes
    Elias B. Hanna
    David Luke Glancy
    Jorge F. Saucedo
    Cardiovascular Drugs and Therapy, 2010, 24 : 61 - 70
  • [23] Current perspectives on British use of adjunctive therapies during coronary interventions
    Swanson, N
    Hogrefe, K
    Lloyd, AS
    Gershlick, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 79 (2-3) : 119 - 125
  • [24] The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
    Tereshchenko, Andrei S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    Abugov, Sergey A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (02) : 277 - 281
  • [25] Antiplatelet Therapy After Percutaneous Coronary Intervention
    Natsuaki, Masahiro
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2022, 86 (05) : 741 - 747
  • [26] Oral antiplatelet therapy for percutaneous coronary revascularization
    Hamdalla, Hussam
    Steinhubl, Steven R.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 69 (05) : 637 - 642
  • [27] Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention
    Higaki, Tadanao
    Kurisu, Satoshi
    Watanabe, Noriaki
    Ikenaga, Hiroki
    Shimonaga, Takashi
    Iwasaki, Toshitaka
    Mitsuba, Naoya
    Ishibashi, Ken
    Dohi, Yoshihiro
    Fukuda, Yukihiro
    Kihara, Yasuki
    HEART AND VESSELS, 2016, 31 (03) : 269 - 274
  • [28] Percutaneous Coronary Interventions on Unprotected Left Main Coronary Artery: Contemporary Outlook of the Problem
    Batyraliev, T. A.
    Fettser, D. V.
    Preobrazhensky, D. V.
    Pershukov, I. V.
    Sidorenko, B. A.
    KARDIOLOGIYA, 2009, 49 (05) : 81 - 92
  • [29] Therapy strategies for acute coronary syndrome and after coronary interventions. Antiplatelet agents and anticoagulants
    Divchev, D.
    Nienaber, C.
    Ince, H.
    INTERNIST, 2011, 52 (11): : 1292 - 1300
  • [30] Antiplatelet therapies in combination for the treatment of patients with stable and unstable coronary artery disease
    Aviles, RJ
    Bhatt, DL
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2002, 13 (03) : 177 - 182
12345